111 related articles for article (PubMed ID: 7897218)
1. Modulation of antibody affinity by an engineered amino acid substitution.
Wong YW; Kussie PH; Parhami-Seren B; Margolies MN
J Immunol; 1995 Apr; 154(7):3351-8. PubMed ID: 7897218
[TBL] [Abstract][Full Text] [Related]
2. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies.
Parhami-Seren B; Margolies MN
J Immunol; 1996 Sep; 157(5):2066-72. PubMed ID: 8757328
[TBL] [Abstract][Full Text] [Related]
3. A single engineered amino acid substitution changes antibody fine specificity.
Kussie PH; Parhami-Seren B; Wysocki LJ; Margolies MN
J Immunol; 1994 Jan; 152(1):146-52. PubMed ID: 8254187
[TBL] [Abstract][Full Text] [Related]
4. Conservation of binding site geometry among p-azophenylarsonate-specific antibodies.
Parhami-Seren B; Kussie PH; Strong RK; Margolies MN
J Immunol; 1993 Mar; 150(5):1829-37. PubMed ID: 8436818
[TBL] [Abstract][Full Text] [Related]
5. Verification of a model of a F(ab) complex with phenylarsonate by oligonucleotide-directed mutagenesis.
Sompuram SR; Sharon J
J Immunol; 1993 Mar; 150(5):1822-8. PubMed ID: 8436817
[TBL] [Abstract][Full Text] [Related]
6. Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme.
Lavoie TB; Drohan WN; Smith-Gill SJ
J Immunol; 1992 Jan; 148(2):503-13. PubMed ID: 1729369
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region.
Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN
J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513
[TBL] [Abstract][Full Text] [Related]
8. Structure-function studies of anti-3-fucosyllactosamine (Le(x)) and galactosylgloboside antibodies.
Snyder JG; Dinh Q; Morrison SL; Padlan EA; Mitchell M; Yu-Lee LY; Marcus DM
J Immunol; 1994 Aug; 153(3):1161-70. PubMed ID: 7913110
[TBL] [Abstract][Full Text] [Related]
9. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta.
Jackson JR; Sathe G; Rosenberg M; Sweet R
J Immunol; 1995 Apr; 154(7):3310-9. PubMed ID: 7897213
[TBL] [Abstract][Full Text] [Related]
11. Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten.
Sharon J; Gefter ML; Wysocki LJ; Margolies MN
J Immunol; 1989 Jan; 142(2):596-601. PubMed ID: 2911012
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of avidity and fine specificity of anti-levan antibodies.
Brorson K; Thompson C; Wei G; Krasnokutsky M; Stein KE
J Immunol; 1999 Dec; 163(12):6694-701. PubMed ID: 10586066
[TBL] [Abstract][Full Text] [Related]
13. Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity.
Pewzner-Jung Y; Simon T; Eilat D
J Immunol; 1996 Apr; 156(8):3065-73. PubMed ID: 8609430
[TBL] [Abstract][Full Text] [Related]
14. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of the somatic hypermutation process leading to antibody D1.3, a high affinity antibody directed against lysozyme.
England P; Nageotte R; Renard M; Page AL; Bedouelle H
J Immunol; 1999 Feb; 162(4):2129-36. PubMed ID: 9973487
[TBL] [Abstract][Full Text] [Related]
16. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
17. Molecular dissection of antibody responses against pneumococcal surface protein A: evidence for diverse DH-less heavy chain gene usage and avidity maturation.
Rohatgi S; Dutta D; Tahir S; Sehgal D
J Immunol; 2009 May; 182(9):5570-85. PubMed ID: 19380805
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of a sequence-specific ssDNA binding lupus autoantibody.
Cleary J; Glick GD
Biochemistry; 2003 Jan; 42(1):30-41. PubMed ID: 12515537
[TBL] [Abstract][Full Text] [Related]
19. Improving the affinity and the fine specificity of an anti-cortisol antibody by parsimonious mutagenesis and phage display.
Chames P; Coulon S; Baty D
J Immunol; 1998 Nov; 161(10):5421-9. PubMed ID: 9820517
[TBL] [Abstract][Full Text] [Related]
20. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis.
Yelton DE; Rosok MJ; Cruz G; Cosand WL; Bajorath J; Hellström I; Hellström KE; Huse WD; Glaser SM
J Immunol; 1995 Aug; 155(4):1994-2004. PubMed ID: 7636250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
